Laxminarayan Bhat

2022

In 2022, Laxminarayan Bhat earned a total compensation of $560K as Chief Executive Officer and President at REVIVA PHARMACEUTICALS HOLDINGS, a 7% decrease compared to previous year.

Compensation breakdown

Bonus$160,000
Salary$400,000
Total$560,000

Bhat received $400K in salary, accounting for 71% of the total pay in 2022.

Bhat also received $160K in bonus.

Rankings

In 2022, Laxminarayan Bhat's compensation ranked 4,148th out of 5,669 executives tracked by ExecPay. In other words, Bhat earned more than 26.8% of executives.

ClassificationRankingPercentile
All
4,148
out of 5,669
27th
Division
Manufacturing
2,342
out of 3,081
24th
Major group
Chemicals And Allied Products
1,141
out of 1,396
18th
Industry group
Drugs
1,071
out of 1,297
17th
Industry
Pharmaceutical Preparations
779
out of 940
17th
Source: SEC filing on October 4, 2023.

Bhat's colleagues

We found two more compensation records of executives who worked with Laxminarayan Bhat at REVIVA PHARMACEUTICALS HOLDINGS in 2022.

2022

Narayan Prabhu

REVIVA PHARMACEUTICALS HOLDINGS

Chief Financial Officer

2022

Marc Cantillon

REVIVA PHARMACEUTICALS HOLDINGS

Chief Medical Officer

News

You may also like